29.94% 3.65

Viridian Therapeutics Inc (VRDN)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Viridian Therapeutics Inc Azioni (VRDN) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-09-30
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	99.81% 0.132	70.57	0.075	0.072	0.086
Operating Expenses	11.12% 122.88	110.58	106.84	93.94	83.57
Benefits Costs and Expenses	-	-	-	-	-
Costs And Expenses	11.12% 122.88	110.58	106.84	93.94	83.57
Operating Income/Loss	206.77% -122.75	-40.01	-106.77	-93.87	-83.48
Nonoperating Income/Loss	55.78% 2.394	5.414	6.032	6.954	6.791
Income/Loss From Continuing Operations Before Tax	99.81% 0.132	70.57	-100.73	-86.91	0.086
Income/Loss From Continuing Operations After Tax	247.86% -120.36	-34.60	-100.73	-86.91	-76.69
Net Income/Loss	247.86% -120.36	-34.60	-100.73	-86.91	-76.69
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

ROIV

$28.54

0.39%

RPRX

$50.76

2.59%

BNTX

$91.77

4.12%

INSM

$139.37

1.11%

RVMD

$146.29

0.33%

ONC

$305.58

3.15%